SUSD2 Suppresses CD8+ T Cell Antitumor Immunity by Targeting IL-2 Receptor Signaling

By
Bob
-
0
301
Susd2−/− effector CD8+ T cells showed enhanced production of antitumor molecules, which consequently blunted tumor growth in multiple syngeneic mouse tumor models.
[Nature Immunology]
Abstract